Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs - Wikidata - awgldk - TriplyDB

Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs

Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs

http://www.wikidata.org/entity/Q36389315

about

Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review MicroRNA Biomarkers for Coronary Artery Disease?Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire?Methodological challenges in utilizing miRNAs as circulating biomarkers Systems Medicine as an Emerging Tool for Cardiovascular Genetics MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?Novel methodologies for biomarker discovery in atherosclerosis Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction Biomarkers of coronary artery disease: the promise of the transcriptome.Profiling of circulating microRNAs after a bout of acute resistance exercise in humans MiRNAs as biomarkers of myocardial infarction: a meta-analysis Heart Failure in Chronic Myocarditis: A Role for microRNAs?MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.The biology of circulating microRNAs in cardiovascular disease.Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery.Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages.Systems Biology and Noninvasive Imaging of Atherosclerosis.Serum extracellular vesicle protein levels are associated with acute coronary syndrome.Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease.Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury.Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis.Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.Microvesicles and exosomes for intracardiac communication.Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs.Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.Gene Expression Signatures and the Spectrum of Coronary Artery Disease.The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation.MiR-146a/b: a family with shared seeds and different roots.Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.Circulating microRNAs indicate cardioprotection by sevoflurane inhalation in patients undergoing off-pump coronary artery bypass surgery.The role of circulating microRNAs in acute coronary syndromes: ready for prime time?Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury.Assessment of microRNAs in patients with unstable angina pectoris.

P2860

Q26746063-3E6438BA-F960-404B-94C5-AC2F36A51711 Q26778604-32F3BA86-6760-415B-A6E4-3A09A017935E Q27001706-26ECE69B-8D8F-473B-AE59-25FE69E32FCA Q27027950-F99510E3-6901-486A-8425-7E3B6F880A28 Q28069197-F43099FC-6E90-442E-B6F3-F171B11B667B Q28076541-70ACFBB5-AFF4-4EB5-A864-37AC598BA710 Q28088373-11AD36CF-241F-411D-B865-3347AC16F9A3 Q30251632-7873C562-A973-4902-BDCC-18ABEC39ED9A Q33624461-A7BF8BE9-EA11-4B2E-95AD-37725A6DEF80 Q33671476-F93527BE-6203-451F-9D7A-6C9103E9A1A4 Q33765102-2D7EAAFC-9DDD-425C-A33C-23EE2AE5DD56 Q34128444-81D5CC49-F65F-4936-BA44-98DF78C43FD3 Q34507146-680256AD-87C0-4FBA-A771-603E6CA020B4 Q34907358-50CF77AF-C8E3-4C41-ADEE-355EA9787E4E Q35095427-4392B960-5A9C-49B4-BC06-19855BC8F0E9 Q35742151-281579FC-4E73-43E3-B87F-C94B463056E4 Q35814698-CE670B4D-7ED8-45FB-B89F-4B75B022D1D3 Q35888026-9E9613CC-6110-40E8-A30F-21B8286467CB Q36003227-799FF9AC-AB37-47EA-9794-ADB2B1C26F10 Q36102976-16D43AF4-7CD5-4730-9823-1DB632CFA6B1 Q36884545-5F0D6606-F948-4AF0-A829-6D3F8B21610A Q37141019-54189164-A091-49AF-8B96-5356FF7B035A Q37179823-F3076DC9-6883-436D-AFE8-E3322C3FF8BB Q37188204-9A240FA6-B58F-4144-80AF-9DA32DAA5BE7 Q37360422-6FF05303-21B8-4D91-9D6E-A92D434C3515 Q37516362-599D047E-DB93-4173-B1F1-9AC6D9690C58 Q38125100-886ED839-8EE7-4400-B494-0634ABB42C72 Q38161836-B14DF3BC-FCE4-4826-9292-4003DA08C6B3 Q38184460-4652CECF-7FDE-46E2-8493-B43286BCD3A4 Q38243743-EF29A2B7-7DA8-4F81-AE1F-7290A8DAD859 Q38274805-E4B59798-5307-4E6B-A3CD-47111775B7DC Q38531858-04E42303-CBA2-4AB5-ACD0-883B4EB9B458 Q38624868-385E983E-D374-4044-AC73-3C71CBDACE8C Q38895580-DC557A0B-D5ED-4388-853C-D93B966C1896 Q38954524-8847013B-749F-48A6-AB9B-0DCE677A065D Q41359989-A834E4C6-BEAE-4D4D-AD37-021A5854135E Q41967015-9F0DBEF6-8232-4D30-B76F-B0605879259F Q42330837-86833DA4-F082-4A56-82F7-831BA84EDD02 Q42370383-E7AC5C73-E882-42BE-AF3F-8A3153D4BC56 Q44243789-C272BA17-FFCC-4CD0-A06B-165FBD45491F

P2860

Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs

http://www.wikidata.org/entity/Q36389315

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Early assessment of acute coro ...... value of circulating microRNAs

@ast

Early assessment of acute coro ...... value of circulating microRNAs

@en

type

label

Early assessment of acute coro ...... value of circulating microRNAs

@ast

Early assessment of acute coro ...... value of circulating microRNAs

@en

prefLabel

Early assessment of acute coro ...... value of circulating microRNAs

@ast

Early assessment of acute coro ...... value of circulating microRNAs

@en

P1433

Q36389315-658491AF-5AFB-4F69-8377-4BF2B42F1D10

P1476

Q36389315-46986267-99CA-4404-9D36-15A2230C30E8

P2093

Q36389315-22CD9762-A89E-4ECE-86DA-8FA8405D38F4

Q36389315-29477259-8302-4C2A-B7E2-5CF2B2F47446

Q36389315-3CF82EA6-5676-4004-B65B-6C5D51450FE5

Q36389315-45B81D41-9564-40BB-BD84-ECC993D23BB5

Q36389315-BA80EC3F-705C-46E7-B750-A7CB8579D61D

Q36389315-DF5FBBBD-2151-4A6A-8369-2F36A373D692

Q36389315-EB668DA7-9925-4F84-86FD-582D74F5EF7F

Q36389315-F0BCD146-74C3-407F-A05A-6A3F8189FD96

P2860

Q36389315-08374385-9D56-418E-BADE-F398329971D2

Q36389315-0C67FE62-53D6-4F8D-8B34-BD55AD659035

Q36389315-16D9DDA9-45C7-4549-9FBB-1E35F03C2BF9

Q36389315-19D37A5F-E6FB-42D4-8058-4289C619C585

Q36389315-1B1FEA7A-4DD4-44EF-A3C9-24B7D3B28EB0

Q36389315-1FC05135-F545-4A84-82D3-5255F6BCCA68

Q36389315-428689D7-99B8-4986-8C17-8F0988CA158B

Q36389315-495F46FA-1DD0-43E8-BF4D-40E48C48F525

Q36389315-5DF1580F-B75B-40CE-8460-C650E2846B44

Q36389315-6167FA12-B892-481E-B1F3-1AE5B8060C3A

P304

Q36389315-19E9614B-E7FB-4B19-997F-83DA7C939048

P31

Q36389315-0C678ED5-1C05-4E6B-9D1A-7535BB8C8BF4

P356

Q36389315-EDFF92F0-9B16-4E62-A94A-42BBFD491851

P433

Q36389315-5ED6BD2D-EA5C-4B73-A128-68AC19899275

P478

Q36389315-4A826B2F-BD11-4A47-80B8-4DFAF7E26DB3

P50

Q36389315-B4BE2133-B0D4-4BF1-AFD7-A34E0D07F5F6

Q36389315-E650B938-06A1-45ED-B687-87E7130A945D

P577

Q36389315-257DCAEE-F841-4781-B14B-32A1E7F9B2DE

P5875

Q36389315-9271863B-41D3-440F-9EB3-75F0BBF36BDD

P698

Q36389315-2C1E2342-52A8-4D1D-A12C-8B9EB32F5A4B

P921

Q36389315-B88D324B-C233-4D0F-9719-AC92470CA1BC

P932

Q36389315-D01BB0EE-4342-4783-A105-21EDDFD0A36F

P356

P1433

EMBO Molecular Medicine

P1476

Early assessment of acute coro ...... value of circulating microRNAs

@en

P2093

Alain van Mil

http://www.w3.org/2001/XMLSchema#string

Arend Mosterd

http://www.w3.org/2001/XMLSchema#string

Arno W Hoes

http://www.w3.org/2001/XMLSchema#string

Evelyn A de Vrey

http://www.w3.org/2001/XMLSchema#string

Joost P G Sluijter

http://www.w3.org/2001/XMLSchema#string

Marieke S Dekker

http://www.w3.org/2001/XMLSchema#string

Martinus I F J Oerlemans

http://www.w3.org/2001/XMLSchema#string

Pieter A Doevendans

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction

Circulating microRNAs as stable blood-based markers for cancer detection.

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

Prediction of mammalian microRNA targets

MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

P304

1176-1185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201201749

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Gerard Pasterkamp

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231613574

http://www.w3.org/2001/XMLSchema#string

P698

23023917

http://www.w3.org/2001/XMLSchema#string

P921

P932

3494874

http://www.w3.org/2001/XMLSchema#string